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Abstract
Vaccinia virus nucleoside triphosphate phosphohydrolase I (NPH I) is an essential early gene transcription termination factor. The
C-terminal end of NPH I binds to the N-terminal end of the H4L subunit (RAP94) of the virion RNA polymerase. This interaction is required
for transcription termination and transcript release. To refine our understanding of the specific amino acids in the C-terminal end of NPH
I involved in binding to H4L, and to develop a collection of mutations exhibiting various degrees of activity to be employed in in vivo
studies, we prepared a set of short deletions, and clustered substitutions of charged amino acids to alanine, or bulky hydrophobic amino acids
to alanine mutations. These NPH I mutant proteins were expressed, purified, and tested for ATPase activity, binding to H4L, and
transcription termination activity. Most mutations in amino acids 609 to 631 exhibited reduced activity. Deletion of the terminal five amino
acids (627–631), or substitution of Y629 with alanine or glutamic acid, dramatically reduced NPH I mediated transcription termination.
Deletion of the terminal F631, or substitution of F631 with alanine, reduced binding to H4L and eliminated termination activity. These
observations demonstrate that the terminal five amino acids directly participate in binding to RNA polymerase and in early gene transcription
termination.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Vaccinia virus gene expression is divided into three
temporal classes (reviewed in Moss, 1990, 2001). Early
genes are transcribed in the virion core by a virion encoded
multi-subunit RNA polymerase, which is modulated by
viral early gene-specific transcription initiation and termi-
nation factors. Intermediate mRNA synthesis begins after
the onset of DNA replication under the direction of both
viral and nuclear proteins. Late gene transcription follows,
requiring a different class of viral gene products and nuclear
proteins. Only early gene transcription is responsive to
signal-dependent transcription termination machinery.
Early gene transcription termination is a complex pro-
cess, which requires multiple factors. Early viral genes
contain the sequence TTTTTNT in the 3-end area, which is
required for termination. TTTTTNT is transcribed yielding
the sequence UUUUUNU embedded within 50 bases of the
mRNA 3 end. This sequence serves as an essential signal,
which is required for termination (Rohrmann et al., 1986;
Yuen and Moss, 1986, 1987). The vaccinia termination
factor (VTF) was isolated from virions and shown to be
required for UUUUUNU-dependent termination in vitro
(Shuman et al., 1987). VTF contains two virus-encoded
subunits, the products of genes D1R and D12L (Morgan et
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al., 1984; Niles et al., 1989). VTF is a multifunctional
protein that also catalyzes the first three steps in mRNA cap
formation (Ensinger et al., 1975; Wei and Moss, 1974) and
serves as an intermediate gene transcription initiation factor
(Vos et al., 1991). Transcription termination also requires
energy provided by the hydrolysis of ATP to ADP and Pi
(Hagler et al., 1994; Shuman and Moss, 1987). ATPase
activity is catalyzed by the viral nucleoside triphosphate
phosphohydrolase I (NPH I) (Christen et al., 1998; Deng
and Shuman, 1998), the product of gene D11L (Broyles and
Moss, 1987; Rodriguez et al., 1986). Single-stranded DNA
induces a conformational change in NPH I (Christen et al.,
1999), which reveals a cryptic ATPase activity (Paoletti and
Moss, 1974). This requirement implies that single-stranded
DNA must be available to bind to NPH I at the time of
termination. Virions possess two multi-subunit forms of
RNA polymerase. One lacks the H4L subunit and is inca-
pable of transcribing early genes (Ahn et al., 1994; Ahn and
Moss, 1992; Deng and Shuman, 1994; Kane and Shuman,
1992). The H4L protein is also known as RAP94, the
product of gene H4L (Ahn and Moss, 1992). The H4L-
containing RNA polymerase transcribes early genes in
vitro. The H4L subunit is involved in providing transcrip-
tion initiation specificity. Furthermore, the N-terminal re-
gion of H4L is essential for transcription termination (Mo-
hamed et al., 2002). Deletion of the C-terminal 28 amino
acids of NPH I eliminates binding to H4L and transcription
termination activity, demonstrating that this interaction is
required for transcription termination in vitro (Mohamed
and Niles, 2000).
To evaluate the significance of the NPH I/H4L interac-
tion in virus-infected cells, mutant genes must be crossed
into the virus and the phenotypes of the mutants must be
investigated. To this end, a collection of site-specific muta-
tions in the C-terminal 28 amino acids of NPH I were
constructed with the intent of identifying a set of mutations
that yielded NPH I proteins possessing a spectrum of activ-
ities. The studies herein describe the effect of amino acid
substitutions on ATPase activity, H4L binding, and tran-
scription termination efficiency in vitro. Within this collec-
tion are mutants that range from wild-type activity to total
inhibition.
Results
Expression of wild-type and mutant NPH I in Escherichia
coli
A set of short deletions, clustered amino acid substitu-
tions, and single amino acid changes were incorporated into
the C-terminal end of genes encoding NPH I (Fig. 1). NPH
I C-terminal mutations were constructed in pET30a. Both
wild-type and mutant NPH I were expressed in E. coli
HMS174(DE3) and isolated by sequential chromatography
of the S100 fraction on nickel agarose and phosphocellulose
(Christen et al., 1999; Deng and Shuman, 1998). SDS de-
naturing gel electrophoretic analysis revealed a set of highly
purified proteins. The wild-type enzyme, along with the
Motif2, Motif5 (Christen et al., 1998), and Y629F mutations
yielded a single full-length component (Fig. 2). Mutants 2,
3, 5, 6, 1–626, and Y629A exhibited a minor degree of
degradation. Mutants Y629E, F631A, 1–630, and the dou-
ble-mutant Motif 2-NPH I1–626 contained two components,
a full-length product that ranged from 30 to 60% of the
protein and a truncation product that was reduced about
10% in length. Since the shorter protein was isolated by
Ni-agarose, the N-terminal his6 tag must be intact and the
C-terminal end must be truncated. Prior studies demon-
strated that such C-terminal truncations retain ATPase ac-
tivity yet do not bind to H4L (Mohamed and Niles, 2000) or
support transcription termination, indicating that their pres-
ence along with the full-length protein will not complicate
the evaluation of this latter group of mutations. Further
support for this contention is provided by Mutant 2, which
exhibits wild-type termination activity and slightly reduced
H4L binding. This pattern of truncations of the mutant NPH
I proteins was found with multiple preparations of induced
enzyme and remains an important caveat for these studies.
Single-stranded DNA-dependent ATPase activity was de-
termined for each purified enzyme as a measure of their
purity and proper folding (Fig. 3). ATPase activity ranged
from about 57 to 105% of the wild-type enzyme. A value of
Fig. 1. Location of the mutations employed in this study. In mutations 2, 3,
5, and 6 charged or bulky hydrophobic amino acids were substituted with
alanine. 1-626 and 1-630 are deletions of the terminal five amino acids or
the terminal F, respectively, Other mutations are single amino acid substi-
tutions, as indicated.
Fig. 2. SDS gel electrophoretic analysis of purified wild-type and mutant
NPH I. NPH I was purified from the S100 fraction of induced bacteria by
sequential chromatography on Ni-agarose and phosphocellulose. After
dialysis into low salt buffer, approximately 2 g of each sample was
denatured, separated in a 12.5% polyacrylamide gel, and stained with
Coomassie brilliant blue. M2-1-626 is a Motif 2 mutant that lacks the five
C-terminal amino acids. This lane was taken from a different gel.
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20,000 units of ATPase activity obtained for the wild-type
protein agrees well with 16,000 and 10,000 (Christen et al.,
1998, 1999; Deng and Shuman, 1998) previously reported.
Effect of C-terminal mutations on transcription
termination in vitro
Transcription termination was measured in reactions
containing the plasmid template pSBterm (Christen et al.,
1998), which has a strong early promoter that drives tran-
scription through a 540 base-pair G-less cassette containing
tandem transcription termination signals embedded in the
nontemplate strand. Transcription yields a 540-base read-
through product that ends when the first G on the template
strand is encountered at the end of the G-less cassette.
Signal-dependent termination generates a shorter 450-base
product. Enzymes were provided by an extract of cells
infected with vaccinia virus tsC50 (Condit et al., 1996).
Cells were infected under conditions that inactivate the
temperature-sensitive NPH I protein, providing an extract
that is transcription competent but requires the addition of
NPH I to participate in early gene transcription termination
(Christen et al., 1998). In addition, extracts possess varying
levels of VTF, so that they must be supplemented with
purified VTF to restore termination activity (Condit et al.,
1996).
The results of a representative set of termination analyses
are presented in Fig. 4A, and the average of multiple anal-
yses are presented graphically in Fig. 4B and summarized in
Table 1. The background level of radioactivity in the sam-
ples that lacked VTF and NPH I yielded a calculated ter-
mination efficiency of 10 to 15%, due to the smear in
radioactivity, which was not subtracted from the values
presented in Fig. 4B. In Table 1, the observed termination
efficiency is reported at two NPH I concentrations. Muta-
tions with reduced termination activity can be readily sorted
into groups differing in the severity of the mutation based
on the stimulation observed over the 10-fold range in NPH
I concentration.
In the case of wild-type NPH I, in the absence of NPH I
and VTF, only a read-through product is observed (Fig. 4A
(top), lane 1 (WT)). Addition of VTF alone had no effect
(lane 2). Addition of NPH I alone restores minimal termi-
nation activity due to the presence of a low level of VTF
activity in the infected cell extract (lane 3). However, ad-
dition of VTF and NPH I yields a concentration-dependent
restoration of transcription-termination activity (Fig. 4A,
lanes 4–7; Fig. 4B). Motif 2 and Motif 5 mutations were
shown previously (Christen et al., 1998) to exhibit dramat-
ically reduced transcription termination activity (Fig. 4A,
bottom; Fig. 4B). Each mutation lies in a sequence motif
that is conserved in Superfamily II helicases and is essential
for ATPase activity (Fig. 3). Mutant 2 (Fig. 4A, left) ex-
hibits wild-type termination activity demonstrating that
these poorly conserved charged amino acids (Fig. 7) do not
play an essential role in this process. Mutants 3 and 5
display reduced termination activity (Fig. 4A and B) at high
NPH I concentrations, suggesting at least 10-fold increase in
the concentration of NPH I was required for half-termina-
tion activity. Mutant 6 displays markedly reduced termina-
tion activity that is just above the background level at the
highest NPH I concentration tested.
Selected mutations in the C-terminal five amino acids
exhibit dramatic reductions in transcription termination in
vitro (Fig. 4A and B, Table 1). Deletion of the terminal five
amino acids (Fig. 4A, right) completely eliminates termina-
tion activity. Substitution of Y629 with glutamic acid also
destroys termination activity. However, substitution of Y629
Fig. 3. NPH I ATPase activity. The single-stranded DNA-dependent ATPase activity was measured for each purified protein using the colorimetric assay for
free inorganic phosphate (Christen et al., 1998). Assays were done in triplicate. Each bar represents the average of at least two sets of measurements. Activity
is described as nmol of inorganic phosphate released in 1 min by 1 pmol of enzyme.
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with alanine yields a protein with substantially reduced
ability to participate in transcription termination (Fig. 4A
and B). These observations demonstrate that the terminal
five amino acids provide an essential termination function.
Importantly, substitution of Y629 with F generates an en-
zyme with full activity, indicating that the hydroxyl group
in tyrosine is not involved in NPH I activity.
The terminal F631 is conserved in many orthopoxvirus
NPH I proteins but it is not found in poxviruses that are
distantly related to vaccinia virus (Fig. 7). F is replaced with
either one or two amino acids or extended up to five amino
acids and terminated with charged residues. Substitution of
F631 with A (Fig. 4A, bottom) yields an enzyme with sub-
stantially reduced termination activity, similar to that ob-
served in the Y629A mutation (Fig. 4A and B). Deletion of
F631 also reduces the termination activity level, indicating
that F631 indeed provides an essential function in the pox-
viruses closely related to vaccinia virus.
Interaction of wild-type and mutant NPH I with the
N-terminal end of H4L
Prior studies demonstrated that NPH I amino acids 457 to
631 were required for binding to the N-terminal end of H4L
containing amino acids 1–256 (Mohamed and Niles, 2000).
Furthermore, deletion of 28 C-terminal amino acids from NPH
I generated a protein that lost its capacity to bind to the
N-terminal end of H4L. To evaluate the effect of the C-
terminal amino acid mutations on H4L binding, a series of
pull-down measurements were conducted. Each assay con-
tained amylose resin bound to a fusion protein consisting of the
mal E protein fused to H4L1–256. C-terminal mutations were
introduced into NPH I457–631 in pCite 4a and 35S-labeled
mutant C-terminal fragments were expressed in a reticulocyte-
based transcription/translation cocktail. Subsequent to incuba-
tion, resins were washed, and bound proteins were denatured,
separated by gel electrophoresis, and observed by fluorogra-
Fig. 4. Transcription termination activity of wild-type and mutant NPH I. (A) This is a composite figure containing the results of a series of transcription
termination assays done at different concentrations of wild-type or mutant NPH I. Transcription-competent extract was prepared from tsC50 virus-infected
cells, which lack NPH I activity (Christen et al., 1998). Transcription of the plasmid template pSBterm yields a full-length 540 nucleotide read-through (RT)
product or a 450-base termination (T) product. Top, WT, wild-type NPH I was tested. Lane 1, no additions. Lane 2, 5 pmol of VTF was added in the absence
of NPHI. Lane 3, 0.05 pmol of wild-type NPH I was added in the absence of VTF. The rest of the lanes contain 5 pmol of VTF plus varying levels (pmol)
of wild-type NPH I. For the rest of the mutants in the composite, the mutant form of NPH I that was tested is listed alongside the results. In each case, the
lane noted 0 had no additions. (B) Graphical depiction of the results obtained by averaging at least three independent termination assays. The background
level of radioactivity in the samples that lacked VTF and NPH I yielded a calculated termination efficiency of 10 to 15%, which was not subtracted from
the values presented in this figure. (), WT; (‚), Mut 2; (E) Mut 3; () Mut 5; (Œ) Mut 6; (F) 1-626; (ƒ), Y629E; ({) Y629A; () Y629F; () 1-630;
() F631A; and () Motif 2.
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phy. Binding was compared to input NPH I457–631, corrected
for trapping by amylose resin containing mal E, and expressed
as a percentage of the input protein. Data from a representative
experiment are presented in Fig. 5A. The average of multiple
pull-down analyses are presented in Fig. 5B and summarized
in Table 1. H4L1–256 precipitated 28% of the input wild-type
35S NPH I457–631 in this experiment, similar to prior observa-
tions (Mohamed and Niles, 2000). Mutant 2 also showed
binding (54% of wild-type NPH I457–631), consistent with its
wild-type level of transcription termination (Fig. 4A and B).
Mutant 5 exhibited an intermediate level of interaction (38%),
which correlates well with its ability to support termination at
a reduced level. Deletion of the five terminal amino acids,
NPH I1–626, or substitution of Y629 with glutamic acid, se-
verely reduces binding to less than 10% of the wild-type
activity. This would be expected based on the inability of these
mutants to support transcription termination (Table 1). Like-
wise, substitution of Y629 with alanine, a mutation that sup-
Table 1
Summary of the ATPase activity, transcription termination activity, and H4L binding for a set of NPH I C-terminal mutations
NPH I ATPase activitya Terminationb [NPH I] Pull-down efficiencyc
0.025 pmol 0.25 pmol
Wild-type 20 47 67 26.9
Mutant 2 D613A, D616A 20.4 43 77 14.5
Mutant 3 K621A,D624A,K626A 17.8 15 39 2.3
Mutant 5 N609A,Y610A,L611A 14.4 17 39 10.1
Mutant 6 N617A,P618A,V619A,I620A 21.0 15 18 5.1
1-626 (627–631) 11.2 11 12 1.9
Y629E 14.6 16 17 2.0
Y629A 10.0 16 23 3.0
Y629F 14.4 53 71 21.6
F631A 15.0 16 22 16.3
1-630 (631) 13.2 15 21 7.9
Motif 2 0.4 18 6 ND
Note. ND, not determined.
a Nanomole of Pi formed per minute per picomole of NPH I.
b Mole percentage of terminated RNA formed.
c Percentage of input NPH I bound to malH4L1–195 resin.
Fig. 5. Interaction of wild-type and mutant NPH I457–631 with Mal E-H4L1–256. (A) This composite contains the results of a single set of interaction
measurements. Amylose resin was prepared that contained bound Mal E-H4L1–256. Resin containing about 2 g of Mal E-H4L1–256 was incubated with 2
l of 35S NPH I457–631, prepared by coupled transcription/translation, with rocking overnight at 4°C. After four washes, the resin-bound protein was
solubilized in SDS, separated by gel electrophoresis, and observed by fluorography. Samples were quantified by densitometry and after correction for the
radioactivity trapped by the Mal E resin control, the percentage of input radioactivity bound was calculated and listed below each mutation. I, 50% of input
radioactivity;M, radiolabeled protein trapped by the control Mal E resin; H4L, radiolabeled protein bound to the Mal E-H4L1–256 resin. (B) Graphical results
of the binding activity for wild-type and mutant NPH I457–631 which is the average of at least three independent measurements.
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ports low but measurable termination activity, yields a protein
that exhibits poor binding (16%) to H4L1–256. A phenylalanine
substitution of Y629 shows near normal interaction (80%) with
H4L1–256. This mutation also provides a wild-type level of
transcription termination activity.
Four mutations exhibit binding activity that does not
correlate with their ability to mediate transcription termina-
tion in vitro. Mutant 3 exhibits low but measurable tran-
scription termination activity yet binds poorly (8.6%) to
H4L1–256. In contrast, Mutant 6 and the deletion of F631
yield forms of NPH I that show intermediate binding activ-
ity (19 and 29%, respectively) but support transcription
termination at only a very low level. Substitution of F631
with alanine generates a NPH I derivative that binds well to
H4L1–256 (61%), yet shows substantially reduced termina-
tion activity. Perhaps this latter group of mutants affects
NPH I in a function that is required subsequent to H4L1–256
binding. Although there is a direct correlation between
transcription termination activity and H4L1–256 binding for
most of the mutants studied, this latter group contains vari-
ants that may provide new insights into the role of NPH I in
transcription termination.
A NPH I deletion mutant lacking amino acids 627–631 is
unable to act as a dominant-negative mutation
Our initial observation related to the importance of the
C-terminal end of NPH I in transcription termination was
based on the inability of C-terminal truncations to act as dom-
inant-negative mutations in vitro (Christen et al., 1998). To
extend this observation, we determined whether the removal of
the terminal five amino acids would also yield a protein that
was unable to exhibit dominant-negative characteristics. Tran-
scription termination assays were conducted in vitro in the
presence of wild-type NPH I and with varying concentrations
of either the NPH I Motif 2 mutation, with the C-terminal
deletion mutation NPH I1–626 or the Motif 2-NPH I1–626 dou-
ble mutant. Consistent with prior studies, addition of the Motif
2 mutation, which lacks ATPase activity but retains an intact
C-terminus, prevents transcription termination (Fig. 6A and B)
in the presence of the wild-type NPH I. This is due to its ability
to compete with wild-type NPH I for binding to H4L (Christen
et al., 1998; Mohamed and Niles, 2000). NPH I1–626 alone or
Motif 2-NPH I1–626 exhibits little reduction in transcription
termination as expected for mutants that have lost the ability to
bind to H4L. Both Motif 2 and NPH I1–626 fail to support
measurable transcription termination in vitro at the levels em-
ployed in these studies.
Discussion
Segments of the NPH I C-terminal amino acid sequence are
well-conserved throughout the poxvirus family (Fig. 7). The
sequence is identical among the orthopoxvirus group members
that are closely related to vaccinia virus, including variola, the
causative agent for smallpox. As the comparison is expanded
to include other poxviruses, the degree of conservation de-
creases. It is most notable that the hydrophobic sequence LIYI,
amino acids 627–630 in vaccinia NPHI, is highly conserved.
To the left, other well-conserved regions can be noted. This
study describes the effects of site-specific mutagenesis of the
C-terminal 23 amino acids on NPH I function.
Mutant 2 (D613A, D616A) lies in a poorly conserved
Fig. 6. NPH I1–626 is unable to inhibit wild-type NPH I participation in transcription termination in vitro. (A) A series of transcription termination assays
was conducted which compared the ability of the Motif 2 mutation, NPH I1–626, and Motif 2-NPH I1–626 to inhibit transcription termination in vitro. The
Motif 2 mutation lacks ATPase activity and fails to function in termination (Christen et al., 1998). Reactions were setup using an extract of tsC50
virus-infected cells (NPH I-), which lacked additions (lane 1) or possessed 0.05 pmol of wild-type NPH I and 5 pmol of VTF (lane 2). Lanes 3 to 10 contained
VTF, wild-type NPH I, and varying amounts of mutant NPH I. () Motif 2 mutant NPH I; (‚) NPH I1–626; (E) Motif 2-NPH I1–626 double mutant.
Full-length read-through transcripts (RT) and terminated RNA (T) were observed by autoradiography of gel-separated samples. (B) RNA synthesis was
quantified by densitometry of the film. The termination efficiency was calculated as described above and plotted against the concentration of mutant NPH
I added to the reaction mixture. The background radioactivity seen in the no addition control was not subtracted in these calculations. These results are the
average of two independent determinations.
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sequence. Appropriately, the exchange of two aspartic acid
residues for alanine showed little effect on either H4L
binding or transcription termination. Mutant 3 (K621A,
D624A, and K626A) contains alanine substitutions of three
charged amino acids. Two mutations, K621A, and K626A,
change well-conserved lysines. These substitutions yield a
protein that shows reduced transcription termination activity
and poor binding to H4L. Likewise, mutant 5 (N609A,
Y610A, L611A) changes three highly conserved amino acids.
This mutation also exhibits reduced termination activity.
However, unlike mutant 3, mutant 5 retains significant bind-
ing to H4L. Mutant 6 (N617A, P618A, V619A,I620A)
substitutes a stretch of bulky hydrophobic amino acids with
alanine. This clustered mutation virtually eliminates both
termination and binding to H4L. It is not clear whether these
amino acids directly interact with H4L amino acid side
chains or provide the correct folding of the C-terminal end
of NPH I, a sequence required for this interaction.
Deletion of the NPH I terminal five amino acids elimi-
nates transcription termination activity and the interaction
with H4L. Substitution of Y629 with alanine significantly
reduces the ability of NPH I to participate in termination
and interact with H4L, demonstrating that Y629 provides an
essential side chain. Insertion of a glutamic acid residue in
place of Y629 eliminates NPH I activity, indicating that the
presence of a charged amino acid in this stretch of hydro-
phobic amino acids is most deleterious. Substitution of Y629
with phenylalanine, however, yields a fully functional pro-
tein, proving that the hydroxyl group on tyrosine is not
needed, and indicates that the tyrosine side chain may be
employed in a hydrophobic interaction with H4L.
The terminal phenylalanine is conserved among or-
thopoxviruses but not among NPH I’s encoded by the more
distantly related viruses (Fig. 7). Substitution of F631 with
alanine dramatically reduces termination activity yet retains
significant H4L binding. This shows that the F631 aromatic
ring plays a role in NPH I function. Deletion of F631 also
reduces NPH I participation in termination yet permits bind-
ing to H4L. These observations support two conclusions.
First, despite the fact that F631 is not conserved through the
poxvirus family, this amino acid plays an important role in
NPH I function among the orthopoxviruses. One would
predict that there is retention of a complimentary sequence
in the orthopoxvirus H4L subunit sequence that would ac-
commodate F631 during NPH I binding. Second, mutation
of F631 provides a protein that lacks termination activity yet
retains significant H4L binding. This suggests that these
mutations may well effect a function in transcription termi-
nation that is required subsequent to binding to H4L. In the
distantly related poxviruses, F631 is most often replaced by
short extensions of two to five amino acids that contain
charged residues. One would predict a coevolution of the
NPH I binding site in H4L that would accommodate both
the increase in length and the acquisition of charged resi-
dues in the C-terminal end of NPH I.
Materials and methods
Cells and viruses
Wild-type vaccinia virus WR and a temperature-sensi-
tive mutation C50 were obtained from Dr. Richard C. Con-
dit. Viruses were propagated at 37 and 31°C, respectively,
on BSC 40 cells, as described (Condit and Motyczka, 1981;
Condit et al., 1983).
Fig. 7. Comparison of the NPH I C-terminal amino acid sequences. The base sequence of the NPH I gene is known for 21 poxvirus strains. Pileup analysis
was conducted at the Poxvirus Bioinformatics Resource Center (www.poxvirus.org) and made available to the public as a Poxvirus Ortholog Cluster. This
figure is based on the 30 terminal amino acids of the vaccinia virus Copenhagen strain NPH I protein. Ten orthopoxviruses closely related to vaccinia virus
Copenhagen possess the identical terminal sequence. This sequence is represented by the top line. Numbers at the top indicate the position of several of the
NPH I mutants described in this report. * Amino acids that were changed. —, amino acids that are present in the insect poxviruses but absent in the other
strains. VV_Cop, Copenhagen strain of vaccinia virus; MYX, myxoma; SFV, shope fibroma virus; LSDV, lumpy skin disease virus; ShPV, sheepox virus;
SPV, swinepox virus; YABA, yaba-like disease virus; FPV, fowlpox virus; MCV, molluscum contagiosum virus; AmEPV, Amsacta moreii entomopoxvirus;
MsEPV, Melanoplus sanguinipes entomopoxvirus.
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Expression plasmid construction and mutagenesis
The preparation of pET30aD11L and pET30a NPH
I457–631 was described (Christen et al., 1999; Mohamed and
Niles, 2000). Mutagenesis of pET30a NPH I457–631 was
conducted by a two-step PCR method using the Quick-
change Site-Directed Mutagenesis kit from Stratagene.
Double-stranded mutant oligonucleotides and flanking oli-
gonucleotides were purchased from Invitrogen. The 5-
flanking oligonucleotide has a BamHI site near its 5 end
and the 3-flanking oligonucleotide had a SalI site at its 5
end. The linear double-stranded DNA products were in-
serted into the pCRIItopo vector from Invitrogen and used
to transform E. coli XL-1 Blue from Stratagene. Kanamy-
cin-resistant colonies were selected and recombinant plas-
mids were identified by gel electrophoresis of BamHI and
SalI digestion of plasmid DNA. The inserts were sequenced
to ensure the identity of each mutation. Full-size pET30a
NPH I mutants were constructed by a three-way ligation.
The major gene D11L fragment was derived from
pGEM3Zf-D11L by cleavage in a 5-flanking Bg1II site
and an internal PvuI site. The C-terminal gene D11L frag-
ment was derived from the pET30aD11L457–631 mutant
plasmid by cleavage at the internal PvuI site and the Sa1I
site in the vector. The two fragments were joined and
inserted into pET30a that had been digested with BamHI
and Sa1I. pET30a-Motif 2-NPH I1–626 was constructed by
swapping BamHI to Sa1I fragments from the two parental
plasmids. Plasmid structures were confirmed by restriction
endonuclease digestion analysis and by determination of the
plasmid sequence in the region of each mutation. pCite4a
derivatives were constructed by insertion of the NcoI to
Sa1I fragment of each pET30aNPH I457–631 mutant into
pCite4a cleaved with NcoI and Sa1I. The DNA sequence in
the region of each mutation confirmed their identity.
Expression and purification of NPH I
Wild-type and mutant pET30a NPH I plasmids were
transformed into E. coli HMS(DE3). NPH I expression was
induced by the addition of 100 M IPTG to mid log phase
cells that had been chilled on ice to 20°C. Cells were shaken
overnight at 20°C. NPH I was purified from 40 g of induced
cell paste by sequential chromatography of the S100 frac-
tion on Ni agarose and phosphocellulose, as described
(Christen et al., 1999; Deng and Shuman, 1998) and the
pooled fractions were dialyzed against Buffer A: 25 mM
Tris–HCl, pH 8.0, 1 mM EDTA, 100 mM NaCl, and 10%
glycerol. Purity was evaluated by Coomassie brilliant blue
staining of proteins separated by SDS–gel electrophoresis.
A value of 0.8 A280 equals 1 mg/ml of NPH I was used to
estimate the concentration of the purified enzyme. Each
mutant protein was purified from multiple independent in-
ductions and yielded consistent results.
Determination of ATPase activity
ATPase activity was measured by a standard colorimet-
ric assay, as described (Christen et al., 1999). An amount of
2.5 pmol of enzyme was added to a standard 0.5 ml reaction
mix containing 40 mM Tris–HCl pH 8, 1 mM ATP, 1 mM
MgCl2, 2 mM DTT, and 200 pg denatured calf thymus
DNA. At selected times, 100 l aliquots were quenched by
the addition of 12.5 mM EDTA and the amount of released
inorganic phosphate was determined. Moles of Pi released
were determined by comparison to a standard curve. Each
assay was done in triplicate. Specific activity is expressed as
nanomoles of Pi released per minute per picomole of NPH
I. The results presented in this article are the average of two
independent ATPase assays, each done in triplicate.
In vitro transcription termination assays
Transcription assays were conducted as described previ-
ously (Condit et al., 1996). Briefly, assays were carried out
in 20 l reactions containing the following: 20 mM Tris–
HCl, pH 8.0, 5 mM MgCl2, 1 mM UTP, 1 mM ATP, 20 M
CTP, 4 Ci [32P]CTP, 0.1 mM 3 O-methyl-GTP, and 0.4
g pBSterm plasmid DNA. RNA polymerase and the re-
quired transcription initiation factor VETF were provided
by adding 6 l of a cytoplasmic extract of virus-infected
cells. VTF, the vaccinia virus transcription factor (Shuman
et al., 1987), was purified as described (Higman et al., 1992)
and 5 pmol was added to each reaction. The virus-infected
cell extract was prepared from cells infected with tsC50
virus under conditions that inactivated the temperature-sen-
sitive NPH I protein (Christen et al., 1998). Transcription
termination requires the addition of NPH I to the reaction
mix. To observe transcription termination, 0 to 0.25 pmol of
either wild-type or mutant NPH I was added to each reac-
tion. RNA synthesis was conducted at 30°C for 30 min.
RNA was isolated, separated by denaturing gel electro-
phoresis, and evaluated by autoradiography. The intensity
of the RNA bands produced was determined by densitom-
etry and the percentage termination was calculated as the
mole ratio of the terminated RNA product over the sum of
the termination product and the read-through transcript. The
assay of each mutant was done from two to four times and
the results presented are an average of the total determina-
tions. The background level of radioactivity in the samples
that lacked VTF and NPH I yielded a calculated termination
efficiency of 10 to 15%.
The ability of termination incompetent mutant NPH I pro-
teins to act as dominant-negative inhibitors of transcription
termination was evaluated. Each reaction contained the stan-
dard ingredients described above in addition to varying levels
of NPH I mutants: Motif 2, which lacks ATPase activity
(Christen et al., 1998); the 1–626 mutant that lacks the C-
terminal five amino acids, and the Motif 2-NPH I1–626 double
mutant. RNA synthesis was determined as described above.
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NPH I–H4L interaction assays
Specific binding of wild-type and mutant NPH I proteins
to the N-terminal region of H4L was measured by pull-
down assays. Each reaction was conducted employing a
fusion of the E. coli mal E protein and H4L1–256 bound to
amylose resin (Mohamed and Niles, 2000). The amount of
resin-bound protein was determined by Coomassie blue
staining of SDS gel-separated amylose resin samples. Wild-
type and mutant NPH I457–631 was radiolabeled with
[35S]met using a coupled transcription/translation reaction
driven by the pCite 4a NPH I plasmids described above. The
Novagen STP3 kit was employed. Each interaction assay
was conducted in 350 l, containing 50 l resin containing
about 2 g of either mal E or the mal E-H4L1–256 fusion, 2
l of the translation product, in a buffer containing 25 mM
Tris–HCl, pH 6.8, 1 mM EDTA, 100 mM NaCl, and 10%
glycerol. Tubes were precoated with 0.1% bovine serum
albumin and dried before use. Samples were rocked over-
night at 4°C, collected by centrifugation, and washed four
times with the same buffer containing 0.05% Tween 20.
Samples were collected by centrifugation, solubilized by
boiling in 20 l SDS sample buffer, and separated by gel
electrophoresis. Radiolabeled proteins were observed by
fluorography and quantified by densitometry. Pull-down
efficiency was calculated as the percentage of input NPH I
in the pellet corrected for protein that was trapped by the
mal E control resin. Pull-down results presented are the
average of three to six determinations.
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